Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Statins Potentiate Aminopeptidase Inhibitor (pro)Drug Activity in Acute Myeloid Leukemia Cells

Jacqueline Cloos, PhD, Godefridus J Peters, PhD, Marjon Al, BSc, Yehuda G Assaraf, PhD, Lixia Wang, PhD, Jack W. Singer, MD, Jorge E. Cortes, MD, Gert J. Ossenkoppele, MD PhD, Gerrit Jansen, PhD

Blood (2018) 132 (Supplement 1): 3945.

https://doi.org/10.1182/blood-2018-99-114447

Published: 2018

Journal Articles

Use of Statins, Survival and Incidence of Thrombosis Among Older Adults with Essential Thrombocythemia: A Population-Based Study

Nikolai Podoltsev, MD PhD, Mengxin Zhu, MPH, Rong Wang, PhD, Amer M. Zeidan, MBBS, MHS, Xiaoyi Wang, MD MPH, Scott F Huntington, MD MPH, Smith Giri, MBBS, Amy J. Davidoff, PhD MS, Steven D. Gore, MD, Xiaomei Ma, PhD

Blood (2018) 132 (Supplement 1): 4865.

https://doi.org/10.1182/blood-2018-99-119118

Published: 2018

Journal Articles

New Antibcma-CAR for Multiple Myeloma

Lorena Perez Amill, PhD, Guillermo Suñe Rodriguez, PhD, Amer Najjar, PhD, Maria Castella Castella, PhD, Alvaro Urbano-Ispizua, MD, Beatriz Martin-Antonio, PhD

Blood (2017) 130 (Supplement 1): 2062.

https://doi.org/10.1182/blood.V130.Suppl_1.2062.2062

Published: 2017

Journal Articles

Long Term Statin Use and Risk of Multiple Myeloma Among 15.5 Million Taiwanese Adults: A Retrospective Cohort Study

Brian C.-H. Chiu, PhD, Jin-Hua Chen, PhD, Yu-Chun Yen, MS, Gregory S. Calip, PharmD, MPH, PhD, Chun-Ru Chien, MD PhD, Habibul Ahsan, MD MMedSc, Ya-Chen T Shih, PhD, Kuang-Fu Cheng, PhD

Blood (2015) 126 (23): 4198.

https://doi.org/10.1182/blood.V126.23.4198.4198

Published: 2015

Journal Articles

The Use of Statin Enhances Chance of Achieving MR4.5 in Chronic Myeloid Leukemia Patients in Chronic Phase Following Imatinib Therapy

Dennis Dong Hwan Kim, MDPhD, Feras Alfraih, MD, Honggi Lee, MD, Jeffrey H. Lipton, MD PhD

Blood (2014) 124 (21): 1804.

https://doi.org/10.1182/blood.V124.21.1804.1804

Published: 2014

Journal Articles

Prospective Analysis Of Statin Use and Risk Of Non-Hodgkin’s Lymphoma In The Women’s Health Initiative Cohort

Pinkal Desai, Robert Wallace, Matthew Anderson, Abdel Alqwasmi, Barbara V. Howard, Chunyuan Wu, Monica Safford, Lisa W. Martin, Nicolas Schlecht, Simin Liu, Jeremy Cetnar, Dominic Cirillo, Allison Jay, JoAnn E. Manson, Michael S. Simon

Blood (2013) 122 (21): 4279.

https://doi.org/10.1182/blood.V122.21.4279.4279

Published: 2013

Journal Articles

Fluvastatin inhibits FLT3 glycosylation in human and murine cells and prolongs survival of mice with FLT3/ITD leukemia

Allen B. Williams, Li Li, Bao Nguyen, Patrick Brown, Mark Levis, Donald Small

Blood (2012) 120 (15): 3069–3079.

https://doi.org/10.1182/blood-2012-01-403493

Published: 2012

Journal Articles

Effects of Fluvastatin on the Expression of Tissue Factor Pathway Inhibitor in Human Umbilical Vein Endothelial Cells

Keiko Maruyama, Eriko Morishita, MD, PhD, Hiroki Torishima, Akiko Sekiya, Hidesaku Asakura, MD, PhD, Shigeki Ohtake, MD, PhD, Shinji Nakao, MD, PhD

Blood (2011) 118 (21): 2253.

https://doi.org/10.1182/blood.V118.21.2253.2253

Published: 2011

Journal Articles

KLF2 and KLF4 Are Essential Mediators of the Anti-Thrombotic Effects of Statins in the Presence of Antiphospholipid/Anti-ß 2 GPI Antibodies,

Kristi L Allen, Ph.D., Mukesh K Jain, MD, Keith R. McCrae, MD

Blood (2011) 118 (21): 3272.

https://doi.org/10.1182/blood.V118.21.3272.3272

Published: 2011

Journal Articles

Statin Treatment Prevents FLT3 Glycosylation and Overcomes Resistance to FLT3 Tyrosine Kinase Inhibitors

Allen Williams, PhD, Li Li, PhD, Bao Nguyen, M.S., Patrick Brown, MD, Mark J. Levis, MD, PhD, Donald Small, MD, PhD

Blood (2011) 118 (21): 1421.

https://doi.org/10.1182/blood.V118.21.1421.1421

Published: 2011

Journal Articles

Statin Treatment Inhibits FLT3 Signaling by Preventing Glycosylation of the Mature Receptor and Leads to Cell Death In Mutant FLT3 Expressing Cells

Allen Williams, PhD, Bao Nguyen, M.S., Li Li, PhD, Patrick Brown, MD, Mark J. Levis, MD, PhD, Donald Small, MD, PhD

Blood (2010) 116 (21): 779.

https://doi.org/10.1182/blood.V116.21.779.779

Published: 2010

Journal Articles

Statin Use Improves Overall Survival and Time to Treatment Failure in Patients with Primary CNS Lymphoma.

Lauren Ciminello, Christiana Toomey, Julien Cobert, Fred H Hochberg, MD, Jeremy S. Abramson, MD, Ephraim Hochberg, MD

Blood (2009) 114 (22): 2496.

https://doi.org/10.1182/blood.V114.22.2496.2496

Published: 2009

Journal Articles

Targeting HMG-CoA Reductase in Acute Lymphoblastic Leukemia (ALL): Statins Inhibit Proliferation and Induce Apoptosis in ALL Cells

David Teachey, MD, Cecilia Sheen, Alix Eden Seif, MD, MPH, Valerie I. Brown, MD, PhD, Stephan A. Grupp, MD, PhD

Blood (2008) 112 (11): 2927.

https://doi.org/10.1182/blood.V112.11.2927.2927

Published: 2008

Journal Articles

Identification of Trigger Factors Initiating an Acute TTP Episode in 68 Patients.

Charis von Auer, MD, Andreas Wilken, MD, Inge Scharrer

Blood (2007) 110 (11): 3969.

https://doi.org/10.1182/blood.V110.11.3969.3969

Published: 2007

Journal Articles

Type II HMG-CoA Reductase Inhibitors (Statins) Provide Acute-Graft-Versus-Host Disease Protection by Th-2 Cytokine Induction While Sparing Graft-Versus-Leukemia Activity.

Robert Zeiser, MD, Sawsan Youssef, Ph.D., Jeanette Baker, Lawrence Steinman, M.D., Robert Negrin, M.D.

Blood (2006) 108 (11): 189.

https://doi.org/10.1182/blood.V108.11.189.189

Published: 2006

Journal Articles

Gene Expression Profiling in Multiple Myeloma Cells Treated with the Novel Anti-Myeloma Agents Zoledronate and Fluvastatin.

Timothy J. Molloy, PhD, Baulch-Brown Cindy, PhD, Yi-Mo Deng, PhD, Andrew Spencer, MBBS, DM, FRACP, FRC, David F. Ma, MBBS, DM, FRACP, FRC

Blood (2005) 106 (11): 5078.

https://doi.org/10.1182/blood.V106.11.5078.5078

Published: 2005

Journal Articles

Use of Pharmacogenetics and Clinical Factors To Predict the Maintenance Dose of Warfarin.

B. F. Gage, MD, C. S. Eby, MD, J. A. Johnson, M. J. Rieder, P. M. Ridker, MD, A. E. Rettie, C. Aquilante, P. E. Milligan, S. Marsh, D. Voora, MD, T. Langaee, D. L. Veenstra, E. Birman-Deych, R. Glynn, D. A. Nickerson, H. L. McLeod

Blood (2005) 106 (11): 550.

https://doi.org/10.1182/blood.V106.11.550.550

Published: 2005

Journal Articles

Fluvastatin-Zometa (FluZom) as A Possible Therapeutic Approach to Plasma Cell Disorders.

Andrew Spencer, DM, Cindy Baulch-Brown, PhD, Kate Reed, BSc, Kevin Lynch, MBBS

Blood (2004) 104 (11): 4937.

https://doi.org/10.1182/blood.V104.11.4937.4937

Published: 2004

Journal Articles

Biphasic Effects of Statins on Angiogenesis-Mediated Processes.

Shaker A. Mousa, PhD, MBA, FACC, FACB, Laura O’Connor, BS, Seema Mohamed, MS

Blood (2004) 104 (11): 3925.

https://doi.org/10.1182/blood.V104.11.3925.3925

Published: 2004

NARROW

Statins Potentiate Aminopeptidase Inhibitor (pro)Drug Activity in Acute Myeloid Leukemia Cells

Use of Statins, Survival and Incidence of Thrombosis Among Older Adults with Essential Thrombocythemia: A Population-Based Study

New Antibcma-CAR for Multiple Myeloma

Long Term Statin Use and Risk of Multiple Myeloma Among 15.5 Million Taiwanese Adults: A Retrospective Cohort Study

The Use of Statin Enhances Chance of Achieving MR4.5 in Chronic Myeloid Leukemia Patients in Chronic Phase Following Imatinib Therapy

Prospective Analysis Of Statin Use and Risk Of Non-Hodgkin’s Lymphoma In The Women’s Health Initiative Cohort

Fluvastatin inhibits FLT3 glycosylation in human and murine cells and prolongs survival of mice with FLT3/ITD leukemia

Effects of Fluvastatin on the Expression of Tissue Factor Pathway Inhibitor in Human Umbilical Vein Endothelial Cells

KLF2 and KLF4 Are Essential Mediators of the Anti-Thrombotic Effects of Statins in the Presence of Antiphospholipid/Anti-ß 2 GPI Antibodies,

Statin Treatment Prevents FLT3 Glycosylation and Overcomes Resistance to FLT3 Tyrosine Kinase Inhibitors

Statin Treatment Inhibits FLT3 Signaling by Preventing Glycosylation of the Mature Receptor and Leads to Cell Death In Mutant FLT3 Expressing Cells

Statin Use Improves Overall Survival and Time to Treatment Failure in Patients with Primary CNS Lymphoma.

Targeting HMG-CoA Reductase in Acute Lymphoblastic Leukemia (ALL): Statins Inhibit Proliferation and Induce Apoptosis in ALL Cells

Identification of Trigger Factors Initiating an Acute TTP Episode in 68 Patients.

Type II HMG-CoA Reductase Inhibitors (Statins) Provide Acute-Graft-Versus-Host Disease Protection by Th-2 Cytokine Induction While Sparing Graft-Versus-Leukemia Activity.

Gene Expression Profiling in Multiple Myeloma Cells Treated with the Novel Anti-Myeloma Agents Zoledronate and Fluvastatin.

Use of Pharmacogenetics and Clinical Factors To Predict the Maintenance Dose of Warfarin.

Fluvastatin-Zometa (FluZom) as A Possible Therapeutic Approach to Plasma Cell Disorders.

Biphasic Effects of Statins on Angiogenesis-Mediated Processes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only